Frontiers in Science and Engineering : (notice n° 54121)
| 000 -LEADER | |
|---|---|
| fixed length control field | 05995nam a22003377a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | IMIST |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 220106b ||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | IMIST |
| Transcribing agency | IMIST |
| Description conventions | rda |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Edition number | 22 |
| Classification number | 616.994 |
| 245 ## - TITLE STATEMENT | |
| Title | Frontiers in Science and Engineering : |
| Remainder of title | International Journal : Life Sciences (Médecine, Health, Agriculture, Biology, Genetics)/ |
| Statement of responsibility, etc | Edited by the Hassan II Academy of Science and Technology of Morocco; Editor-in-chief O.Fassi-Fehri |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | Rabat |
| 264 ## - Production, Publication, Distribution, Manufacture, and Copyright Notice | |
| Place of production, publication, distribution, manufacture | Rabat |
| Name of producer, publisher, distributor, manufacturer | Académie Hassan II des sciences et techniques |
| Date of production, publication, distribution, manufacture, or copyright notice | 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 104 pages ; |
| 336 ## - CONTENT TYPE | |
| Source | rda content |
| Content Type Term | text |
| Content Type Code | txt |
| 337 ## - MEDIA TYPE | |
| Source | rdamedia |
| Media Type Term | unmediated |
| Media Type Code | n |
| 338 ## - CARRIER TYPE | |
| Source | rdacarrier |
| Carrier Type Term | volume |
| Carrier Type Code | nc |
| 490 ## - SERIES STATEMENT | |
| Series statement | Académie Hassan II des sciences et techniques |
| Volume number/sequential designation | Volume 8- supplement 2; |
| International Standard Serial Number | 2028-7615 |
| 505 ## - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Combating Cancer: New Approaches through Improved Diagnosis and Immunotherapy<br/>Albert SASSON<br/><br/>The Rising World of MicroRNAs: Oncogenes and Tumor Suppressors in Cancer<br/>Fadila GUESSOUS, Ying ZHANG and Roger ABOUNADER<br/><br/>Molecular characterization of triple negative breast cancers: potential<br/>application for targeted therapy<br/>Giovanna CHIORINO<br/><br/>The Molecular Basis of Viro-Induced Carcinogenesis<br/>Mohammed EL MZIBRI, Imane CHAOUI, Meriem KHYATTI and Mohammed ATTALEB<br/><br/>Assessment of Molecular Biomarkers for Bladder Cancer Diagnosis, Grading and Prognosis<br/>Hajar AHANIDI, Chaimae HAFIDI ALAOUI, Mounia BENSAID, Mohammed EL MZIBRI, Ahmed AMEUR, Mohammed ABBAR, Abderrahmane AL BOUZIDI and Mohammed Attaleb<br/><br/>Evaluation of GPX1 Pro198Leu Polymorphism, GSTP1 Expression and Gene Promoter methylation in Moroccan patients with Bladder Cancer<br/>Khaoula HADAMI, Nadia DAKKA, Mounia BENSAID, Ahmed AMEUR, Hafsa CHAHDI, Mohamed OUKABLI, Abderrahmane AL BOUZIDI, Mohammed ATTALEB and Mohammed EL MZIBRI<br/><br/>Epidermal Growth Factor Receptor Mutational Profile in Lung Cancer Moroccan Cohort<br/>Houda KAANANE, Hicham EL ATTAR, Amal LOUAHABBI, IGOT CASA, Hind BERRADI,Hind HASSANI IDRISSI, Meriem KHYATTI, Sellama NADIFI<br/><br/>Expression Profile of Breast Cancer in Moroccan Women<br/>Salah Eddine AYOUBI, Paola OSTANO, Maurizia MELLO-GRAND, Ilaria GREGNANIN,Mohamed ELKARROUMI, Giovanna CHIORINO and Sellama NADIFI<br/><br/>Comparative Study of Clinicopathological Features and Prognostic in Triple Negative and Non-Triple Negative Breast Cancer in the North of Morocco<br/>Touria DERKAOUI, Mohamed MANSOURI, Joaira BAKKACH, Mohamed FIHRI,Ali LOUDIYI, Amina BARAKAT, Naima GHAILANI NOUROUTI and Mohcine BENNANI MECHITA<br/> |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Cancer is a major public-health problem in Africa. However the advances made in the treatment<br/>of these range of diseases over the past decade are hopeful and the emergence of targeted therapies<br/>has changed the evolution of some cancers, known to have a poor prognosis. These therapies<br/>have a very high cost which makes them out of reach of the majority of patients in developing<br/>countries. There are typically three main types of cancer treatment through surgery, radiotherapy<br/>and chemotherapy. The latter is undoubtedly saving lives but at the cost of significant toxicity.<br/>The risk of toxicity associated with chemotherapy must therefore be weighed against the risk of<br/>cancer progression due to the discontinuation of systemic therapy.<br/>Thanks to precision medicine, a revolution is also in progress. Targeted therapies are thus<br/>currently carried out and help understanding the mechanisms of cancer-cell function. Targeted<br/>therapy uses a “selective” drug that attacks cancer cells by spotting a specific target. This target<br/>can be a receptor, a gene or a protein, and the targeted action must intervene at a precise stage of<br/>the development of the tumor cell, protecting as much as possible the healthy cells.<br/>Targeted therapy is mainly involved in signal transduction pathways, which controls cell<br/>multiplication. The so-called tyrosine kinase pathway is the best known up to date. Monoclonal<br/>antibodies or enzymatic inhibitors can block this pathway. By acting on specific receptors, these<br/>drugs can block the growth of cancer cells, by preventing the tumor from inducing its own<br/>vascularization; or they can stimulate the immune system of the patient against cancer cells.<br/>Also should be mentioned the recently approved immunotherapy treatment of non small-cell<br/>metastatic bronchial-cell cancers. Targeted therapy can also control cancer-cell death, enhancing<br/>apoptosis or the natural death of the cell. Some products are being developed for the treatment<br/>of cancers of the upper aero-digestive tract (head and neck). These are examples of targeted<br/>therapies, being tried and used up to date and which have significantly improved the treatment<br/>of cancers. This was the focus of the three-day Summer School (16-18 July 2018), organized by<br/>the Hassan II Academy of Science and Technology (Life Sciences and Biotechnology section),<br/>in close cooperation with the Al Akhawayn University at Ifrane, Morocco.<br/>The program also aimed to the discuss the situation in Morocco and Africa, as well as on how to<br/>make the new therapies available to the patients. The participants in the summer school included,<br/>in addition to renowned experts from Morocco, Africa and other countries, 15 young researchers<br/>(including two from Africa) and 25 senior researchers from various Moroccan institutions.<br/>This special issue of Frontiers in Science and Engineering includes eight articles or presentations<br/>of from this summer school.<br/>A. Sasson, S. Nadifi, A. Filali-Maltouf and C. Martínez Alonso<br/>Members of the Life Sciences and Biotechnology Section |
| 651 #0 - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME | |
| 9 (RLIN) | 13411 |
| Geographic name | Maroc. |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | Médecine |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | Health |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | biology |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | Cancer |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | Tumeur |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fassi-Fehri, O. |
| 9 (RLIN) | 37393 |
| Relator term | Directeur de la publication |
| 710 ## - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | Académie Hassan II des sciences et techniques |
| 9 (RLIN) | 298 |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Link text | Accéder au Full text |
| Uniform Resource Identifier | <a href="https://revues.imist.ma/index.php/fsejournal/issue/viewIssue/1730/604">https://revues.imist.ma/index.php/fsejournal/issue/viewIssue/1730/604</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | |
| Item type | Editions nationales |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Permanent location | Current location | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Koha item type | Public note | Price effective from |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| La bibliothèque des Sciences Médicales et Pharmaceutiques | La bibliothèque des Sciences Médicales et Pharmaceutiques | 01/06/2022 | 616.994 ACA VOL.8 | 0000000033547 | 01/06/2022 | Editions nationales | Volume 8- supplement 2- 2019 | |||||||
| La bibliothèque des Sciences Médicales et Pharmaceutiques | La bibliothèque des Sciences Médicales et Pharmaceutiques | 01/06/2022 | 616.994 ACA VOL.8 | 0000000033548 | 01/06/2022 | Editions nationales | Volume 8- supplement 2- 2019 | 01/06/2022 | ||||||
| La bibliothèque des Sciences Médicales et Pharmaceutiques | La bibliothèque des Sciences Médicales et Pharmaceutiques | 01/06/2022 | 616.994 ACA VOL.8 | 0000000033549 | 01/06/2022 | Editions nationales | Volume 8- supplement 2- 2019 | 01/06/2022 | ||||||
| La bibliothèque des Sciences Médicales et Pharmaceutiques | La bibliothèque des Sciences Médicales et Pharmaceutiques | 01/06/2022 | 616.994 ACA VOL.8 | 0000000033550 | 01/06/2022 | Editions nationales | Volume 8- supplement 2- 2019 | 01/06/2022 |